BioCentury | Apr 15, 2013
Company News

Ilex, PRN Research Inc. deal

...Indianapolis, Ind.) for the clinical development of two Lilly cancer compounds (see BioCentury May 27). Ilex Oncology Inc....
BioCentury | Apr 15, 2013
Company News

Ilex, Pharma Forschung Kaufbeuen GmbH deal

...one year, and another 9 percent in two years. The company will be renamed PFK-ILEX. Ilex Oncology Inc....
BioCentury | Apr 15, 2013
Company News

Ilex, LeukoSite deal

...patients suggested that the degree of lymphocyte depletion was too great for chronic RA therapy. Ilex Oncology Inc....
BioCentury | Apr 9, 2009
Targets & Mechanisms

Next-gen polyamine attack

...The development of eflornithine monotherapy to treat cancer suffered a significant setback in 2004 when Ilex Oncology Inc....
BioCentury | May 19, 2008
Company News

Southwest Foundation for Biomedical Research cancer, genitourinary, endocrine news

...round. Ze'ev Shaked will be president, CEO and a director. Shaked was formerly COO of Ilex Oncology Inc....
BioCentury | Feb 4, 2008
Product Development

Velcade's true believers

...rights was too cumbersome and agreed to sell its stake in a joint venture with Ilex Oncology Inc....
BioCentury | Jan 7, 2008
Strategy

Selling out to reach the finish line

...Inc. in 2005 ( see BioCentury, March 21, 2005 ). The company in-licensed QRX-401 from Ilex Oncology Inc....
BioCentury | Aug 14, 2006
Company News

Erimos scientific advisory board update

...EVP at the Translational Genomics Research Institute; and Steven Weitman, former CMO and SVP of Ilex Oncology Inc. WIR...
BioCentury | Jun 19, 2006
Finance

Millennium M&A comps

...it didn’t already own 2004 Pfizer Esperion $22.70 $35.00 54% $1.3B in cash 2005 Genzyme Ilex...
BioCentury | Apr 17, 2006
Politics, Policy & Law

Global health HAND out

...Chagas disease. The other targets malaria. GENZ's work on trypanosomiasis stems from its acquisition of Ilex Oncology Inc....
Items per page:
1 - 10 of 334
BioCentury | Apr 15, 2013
Company News

Ilex, PRN Research Inc. deal

...Indianapolis, Ind.) for the clinical development of two Lilly cancer compounds (see BioCentury May 27). Ilex Oncology Inc....
BioCentury | Apr 15, 2013
Company News

Ilex, Pharma Forschung Kaufbeuen GmbH deal

...one year, and another 9 percent in two years. The company will be renamed PFK-ILEX. Ilex Oncology Inc....
BioCentury | Apr 15, 2013
Company News

Ilex, LeukoSite deal

...patients suggested that the degree of lymphocyte depletion was too great for chronic RA therapy. Ilex Oncology Inc....
BioCentury | Apr 9, 2009
Targets & Mechanisms

Next-gen polyamine attack

...The development of eflornithine monotherapy to treat cancer suffered a significant setback in 2004 when Ilex Oncology Inc....
BioCentury | May 19, 2008
Company News

Southwest Foundation for Biomedical Research cancer, genitourinary, endocrine news

...round. Ze'ev Shaked will be president, CEO and a director. Shaked was formerly COO of Ilex Oncology Inc....
BioCentury | Feb 4, 2008
Product Development

Velcade's true believers

...rights was too cumbersome and agreed to sell its stake in a joint venture with Ilex Oncology Inc....
BioCentury | Jan 7, 2008
Strategy

Selling out to reach the finish line

...Inc. in 2005 ( see BioCentury, March 21, 2005 ). The company in-licensed QRX-401 from Ilex Oncology Inc....
BioCentury | Aug 14, 2006
Company News

Erimos scientific advisory board update

...EVP at the Translational Genomics Research Institute; and Steven Weitman, former CMO and SVP of Ilex Oncology Inc. WIR...
BioCentury | Jun 19, 2006
Finance

Millennium M&A comps

...it didn’t already own 2004 Pfizer Esperion $22.70 $35.00 54% $1.3B in cash 2005 Genzyme Ilex...
BioCentury | Apr 17, 2006
Politics, Policy & Law

Global health HAND out

...Chagas disease. The other targets malaria. GENZ's work on trypanosomiasis stems from its acquisition of Ilex Oncology Inc....
Items per page:
1 - 10 of 334